Global Gabapentin Market Growth 2021-2026


Jul, 2021 | Report ID: 203147 | 117 | Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Gabapentin will have significant change from previous year. By the most conservative estimates of global Gabapentin market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1482 million in 2020. Over the next five years the Gabapentin market will register a 1.9% CAGR in terms of revenue, the global market size will reach US$ 1595.9 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Capsule

Tablet

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Epilepsy

Neuropathic Pain

Restless Legs Syndrome

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Pfizer

Assertio Therapeutics

TEVA

Mylan

Arbor Pharma

Novartis

Apotex

Sun Pharmaceutical

Aurobindo Pharma

Intas

Amneal

Marksans Pharma

Glenmark

Alkem

Jiangsu Enhua

Jiangsu Hengrui

Sailike


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gabapentin Consumption 2016-2026

2.1.2 Gabapentin Consumption CAGR by Region

2.2 Gabapentin Segment by Type

2.2.1 Capsule

2.2.2 Tablet

2.3 Gabapentin Sales by Type

2.3.1 Global Gabapentin Sales Market Share by Type (2016-2021)

2.3.2 Global Gabapentin Revenue and Market Share by Type (2016-2021)

2.3.3 Global Gabapentin Sale Price by Type (2016-2021)

2.4 Gabapentin Segment by Application

2.4.1 Epilepsy

2.4.2 Neuropathic Pain

2.4.3 Restless Legs Syndrome

2.4.4 Others

2.5 Gabapentin Sales by Application

2.5.1 Global Gabapentin Sale Market Share by Application (2016-2021)

2.5.2 Global Gabapentin Revenue and Market Share by Application (2016-2021)

2.5.3 Global Gabapentin Sale Price by Application (2016-2021)

3 Global Gabapentin by Company

3.1 Global Gabapentin Sales Market Share by Company

3.1.1 Global Gabapentin Sales by Company (2019-2021)

3.1.2 Global Gabapentin Sales Market Share by Company (2019-2021)

3.2 Global Gabapentin Revenue Market Share by Company

3.2.1 Global Gabapentin Revenue by Company (2019-2021)

3.2.2 Global Gabapentin Revenue Market Share by Company (2019-2021)

3.3 Global Gabapentin Sale Price by Company

3.4 Global Manufacturers Gabapentin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Gabapentin Product Location Distribution

3.4.2 Players Gabapentin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Gabapentin by Region

4.1 Global Gabapentin by Region

4.1.1 Global Gabapentin Sales by Region

4.1.2 Global Gabapentin Revenue by Region

4.2 Americas Gabapentin Sales Growth

4.3 APAC Gabapentin Sales Growth

4.4 Europe Gabapentin Sales Growth

4.5 Middle East & Africa Gabapentin Sales Growth

5 Americas

5.1 Americas Gabapentin Sales by Country

5.1.1 Americas Gabapentin Sales by Country (2016-2021)

5.1.2 Americas Gabapentin Revenue by Country (2016-2021)

5.2 Americas Gabapentin Sales by Type

5.3 Americas Gabapentin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gabapentin Sales by Region

6.1.1 APAC Gabapentin Sales by Region (2016-2021)

6.1.2 APAC Gabapentin Revenue by Region (2016-2021)

6.2 APAC Gabapentin Sales by Type

6.3 APAC Gabapentin Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Gabapentin by Country

7.1.1 Europe Gabapentin Sales by Country (2016-2021)

7.1.2 Europe Gabapentin Revenue by Country (2016-2021)

7.2 Europe Gabapentin Sales by Type

7.3 Europe Gabapentin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gabapentin by Country

8.1.1 Middle East & Africa Gabapentin Sales by Country (2016-2021)

8.1.2 Middle East & Africa Gabapentin Revenue by Country (2016-2021)

8.2 Middle East & Africa Gabapentin Sales by Type

8.3 Middle East & Africa Gabapentin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Gabapentin Distributors

10.3 Gabapentin Customer

11 Global Gabapentin Market Forecast

11.1 Global Gabapentin Forecast by Region

11.1.1 Global Gabapentin Forecast by Regions (2021-2026)

11.2.2 Global Gabapentin Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Gabapentin Forecast by Type

11.7 Global Gabapentin Forecast by Application

12 Key Players Analysis

12.1 Pfizer

12.1.1 Pfizer Company Information

12.1.2 Pfizer Gabapentin Product Offered

12.1.3 Pfizer Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Pfizer Main Business Overview

12.1.5 Pfizer Latest Developments

12.2 Assertio Therapeutics

12.2.1 Assertio Therapeutics Company Information

12.2.2 Assertio Therapeutics Gabapentin Product Offered

12.2.3 Assertio Therapeutics Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Assertio Therapeutics Main Business Overview

12.2.5 Assertio Therapeutics Latest Developments

12.3 TEVA

12.3.1 TEVA Company Information

12.3.2 TEVA Gabapentin Product Offered

12.3.3 TEVA Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 TEVA Main Business Overview

12.3.5 TEVA Latest Developments

12.4 Mylan

12.4.1 Mylan Company Information

12.4.2 Mylan Gabapentin Product Offered

12.4.3 Mylan Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Mylan Main Business Overview

12.4.5 Mylan Latest Developments

12.5 Arbor Pharma

12.5.1 Arbor Pharma Company Information

12.5.2 Arbor Pharma Gabapentin Product Offered

12.5.3 Arbor Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Arbor Pharma Main Business Overview

12.5.5 Arbor Pharma Latest Developments

12.6 Novartis

12.6.1 Novartis Company Information

12.6.2 Novartis Gabapentin Product Offered

12.6.3 Novartis Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Novartis Main Business Overview

12.6.5 Novartis Latest Developments

12.7 Apotex

12.7.1 Apotex Company Information

12.7.2 Apotex Gabapentin Product Offered

12.7.3 Apotex Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Apotex Main Business Overview

12.7.5 Apotex Latest Developments

12.8 Sun Pharmaceutical

12.8.1 Sun Pharmaceutical Company Information

12.8.2 Sun Pharmaceutical Gabapentin Product Offered

12.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Sun Pharmaceutical Main Business Overview

12.8.5 Sun Pharmaceutical Latest Developments

12.9 Aurobindo Pharma

12.9.1 Aurobindo Pharma Company Information

12.9.2 Aurobindo Pharma Gabapentin Product Offered

12.9.3 Aurobindo Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Aurobindo Pharma Main Business Overview

12.9.5 Aurobindo Pharma Latest Developments

12.10 Intas

12.10.1 Intas Company Information

12.10.2 Intas Gabapentin Product Offered

12.10.3 Intas Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Intas Main Business Overview

12.10.5 Intas Latest Developments

12.11 Amneal

12.11.1 Amneal Company Information

12.11.2 Amneal Gabapentin Product Offered

12.11.3 Amneal Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Amneal Main Business Overview

12.11.5 Amneal Latest Developments

12.12 Marksans Pharma

12.12.1 Marksans Pharma Company Information

12.12.2 Marksans Pharma Gabapentin Product Offered

12.12.3 Marksans Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Marksans Pharma Main Business Overview

12.12.5 Marksans Pharma Latest Developments

12.13 Glenmark

12.13.1 Glenmark Company Information

12.13.2 Glenmark Gabapentin Product Offered

12.13.3 Glenmark Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Glenmark Main Business Overview

12.13.5 Glenmark Latest Developments

12.14 Alkem

12.14.1 Alkem Company Information

12.14.2 Alkem Gabapentin Product Offered

12.14.3 Alkem Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Alkem Main Business Overview

12.14.5 Alkem Latest Developments

12.15 Jiangsu Enhua

12.15.1 Jiangsu Enhua Company Information

12.15.2 Jiangsu Enhua Gabapentin Product Offered

12.15.3 Jiangsu Enhua Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Jiangsu Enhua Main Business Overview

12.15.5 Jiangsu Enhua Latest Developments

12.16 Jiangsu Hengrui

12.16.1 Jiangsu Hengrui Company Information

12.16.2 Jiangsu Hengrui Gabapentin Product Offered

12.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Jiangsu Hengrui Main Business Overview

12.16.5 Jiangsu Hengrui Latest Developments

12.17 Sailike

12.17.1 Sailike Company Information

12.17.2 Sailike Gabapentin Product Offered

12.17.3 Sailike Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 Sailike Main Business Overview

12.17.5 Sailike Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Gabapentin Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Capsule

Table 3. Major Players of Tablet

Table 4. Global Gabapentin Sales by Type (2016-2021) & (M Unit)

Table 5. Global Gabapentin Sales Market Share by Type (2016-2021)

Table 6. Global Gabapentin Revenue by Type (2016-2021) & ($ million)

Table 7. Global Gabapentin Revenue Market Share by Type (2016-2021)

Table 8. Global Gabapentin Sale Price by Type (2016-2021)

Table 9. Global Gabapentin Sales by Application (2016-2021) & (M Unit)

Table 10. Global Gabapentin Sales Market Share by Application (2016-2021)

Table 11. Global Gabapentin Value by Application (2016-2021)

Table 12. Global Gabapentin Revenue Market Share by Application (2016-2021)

Table 13. Global Gabapentin Sale Price by Application (2016-2021)

Table 14. Global Gabapentin Sales by Company (2019-2021) & (M Unit)

Table 15. Global Gabapentin Sales Market Share by Company (2019-2021)

Table 16. Global Gabapentin Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Gabapentin Revenue Market Share by Company (2019-2021)

Table 18. Global Gabapentin Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Gabapentin Producing Area Distribution and Sales Area

Table 20. Players Gabapentin Products Offered

Table 21. Gabapentin Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Gabapentin Sales by Region (2016-2021) (M Unit)

Table 25. Global Gabapentin Sales Market Share by Region (2016-2021)

Table 26. Global Gabapentin Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Gabapentin Revenue Market Share by Region (2016-2021)

Table 28. Americas Gabapentin Sales by Country (2016-2021) & (M Unit)

Table 29. Americas Gabapentin Sales Market Share by Country (2016-2021)

Table 30. Americas Gabapentin Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Gabapentin Revenue Market Share by Country (2016-2021)

Table 32. Americas Gabapentin Sales by Type (2016-2021) & (M Unit)

Table 33. Americas Gabapentin Sales Market Share by Type (2016-2021)

Table 34. Americas Gabapentin Sales by Application (2016-2021) & (M Unit)

Table 35. Americas Gabapentin Sales Market Share by Application (2016-2021)

Table 36. APAC Gabapentin Sales by Region (2016-2021) & (M Unit)

Table 37. APAC Gabapentin Sales Market Share by Region (2016-2021)

Table 38. APAC Gabapentin Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Gabapentin Revenue Market Share by Region (2016-2021)

Table 40. APAC Gabapentin Sales by Type (2016-2021) & (M Unit)

Table 41. APAC Gabapentin Sales Market Share by Type (2016-2021)

Table 42. APAC Gabapentin Sales by Application (2016-2021) & (M Unit)

Table 43. APAC Gabapentin Sales Market Share by Application (2016-2021)

Table 44. Europe Gabapentin Sales by Country (2016-2021) & (M Unit)

Table 45. Europe Gabapentin Sales Market Share by Country (2016-2021)

Table 46. Europe Gabapentin Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Gabapentin Revenue Market Share by Country (2016-2021)

Table 48. Europe Gabapentin Sales by Type (2016-2021) & (M Unit)

Table 49. Europe Gabapentin Sales Market Share by Type (2016-2021)

Table 50. Europe Gabapentin Sales by Application (2016-2021) & (M Unit)

Table 51. Europe Gabapentin Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Gabapentin Sales by Country (2016-2021) & (M Unit)

Table 53. Middle East & Africa Gabapentin Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Gabapentin Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Gabapentin Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Gabapentin Sales by Type (2016-2021) & (M Unit)

Table 57. Middle East & Africa Gabapentin Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Gabapentin Sales by Application (2016-2021) & (M Unit)

Table 59. Middle East & Africa Gabapentin Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Gabapentin

Table 61. Key Application and Potential Industries of Gabapentin

Table 62. Key Challenges of Gabapentin

Table 63. Key Trends of Gabapentin

Table 64. Gabapentin Distributors List

Table 65. Gabapentin Customer List

Table 66. Global Gabapentin Sales Forecast by Region (2021-2026) & (M Unit)

Table 67. Global Gabapentin Consumption Market Forecast by Region

Table 68. Global Gabapentin Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Gabapentin Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Gabapentin Sales Forecast by Country (2021-2026) & (M Unit)

Table 71. Americas Gabapentin Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Gabapentin Sales Forecast by Region (2021-2026) & (M Unit)

Table 73. APAC Gabapentin Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Gabapentin Sales Forecast by Country (2021-2026) & (M Unit)

Table 75. Europe Gabapentin Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Gabapentin Sales Forecast by Country (2021-2026) & (M Unit)

Table 77. Middle East & Africa Gabapentin Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Gabapentin Sales Forecast by Type (2021-2026) & (M Unit)

Table 79. Global Gabapentin Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Gabapentin Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Gabapentin Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Gabapentin Sales Forecast by Application (2021-2026) & (M Unit)

Table 83. Global Gabapentin Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Gabapentin Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Gabapentin Revenue Market Share Forecast by Application (2021-2026)

Table 86. Pfizer Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 87. Pfizer Gabapentin Product Offered

Table 88. Pfizer Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 89. Pfizer Main Business

Table 90. Pfizer Latest Developments

Table 91. Assertio Therapeutics Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 92. Assertio Therapeutics Gabapentin Product Offered

Table 93. Assertio Therapeutics Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 94. Assertio Therapeutics Main Business

Table 95. Assertio Therapeutics Latest Developments

Table 96. TEVA Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 97. TEVA Gabapentin Product Offered

Table 98. TEVA Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 99. TEVA Main Business

Table 100. TEVA Latest Developments

Table 101. Mylan Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 102. Mylan Gabapentin Product Offered

Table 103. Mylan Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 104. Mylan Main Business

Table 105. Mylan Latest Developments

Table 106. Arbor Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 107. Arbor Pharma Gabapentin Product Offered

Table 108. Arbor Pharma Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 109. Arbor Pharma Main Business

Table 110. Arbor Pharma Latest Developments

Table 111. Novartis Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 112. Novartis Gabapentin Product Offered

Table 113. Novartis Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 114. Novartis Main Business

Table 115. Novartis Latest Developments

Table 116. Apotex Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 117. Apotex Gabapentin Product Offered

Table 118. Apotex Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 119. Apotex Main Business

Table 120. Apotex Latest Developments

Table 121. Sun Pharmaceutical Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 122. Sun Pharmaceutical Gabapentin Product Offered

Table 123. Sun Pharmaceutical Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 124. Sun Pharmaceutical Main Business

Table 125. Sun Pharmaceutical Latest Developments

Table 126. Aurobindo Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 127. Aurobindo Pharma Gabapentin Product Offered

Table 128. Aurobindo Pharma Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 129. Aurobindo Pharma Main Business

Table 130. Aurobindo Pharma Latest Developments

Table 131. Intas Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 132. Intas Gabapentin Product Offered

Table 133. Intas Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 134. Intas Main Business

Table 135. Intas Latest Developments

Table 136. Amneal Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 137. Amneal Gabapentin Product Offered

Table 138. Amneal Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 139. Amneal Main Business

Table 140. Amneal Latest Developments

Table 141. Marksans Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 142. Marksans Pharma Gabapentin Product Offered

Table 143. Marksans Pharma Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 144. Marksans Pharma Main Business

Table 145. Marksans Pharma Latest Developments

Table 146. Glenmark Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 147. Glenmark Gabapentin Product Offered

Table 148. Glenmark Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 149. Glenmark Main Business

Table 150. Glenmark Latest Developments

Table 151. Alkem Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 152. Alkem Gabapentin Product Offered

Table 153. Alkem Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 154. Alkem Main Business

Table 155. Alkem Latest Developments

Table 156. Jiangsu Enhua Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 157. Jiangsu Enhua Gabapentin Product Offered

Table 158. Jiangsu Enhua Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 159. Jiangsu Enhua Main Business

Table 160. Jiangsu Enhua Latest Developments

Table 161. Jiangsu Hengrui Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 162. Jiangsu Hengrui Gabapentin Product Offered

Table 163. Jiangsu Hengrui Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 164. Jiangsu Hengrui Main Business

Table 165. Jiangsu Hengrui Latest Developments

Table 166. Sailike Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 167. Sailike Gabapentin Product Offered

Table 168. Sailike Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 169. Sailike Main Business

Table 170. Sailike Latest Developments

List of Figures

Figure 1. Picture of Gabapentin

Figure 2. Gabapentin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Gabapentin Sales Growth Rate 2016-2026 (M Unit)

Figure 7. Global Gabapentin Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Gabapentin Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Capsule

Figure 10. Product Picture of Tablet

Figure 11. Global Gabapentin Sales Market Share by Type in 2020

Figure 12. Global Gabapentin Revenue Market Share by Type (2016-2021)

Figure 13. Gabapentin Consumed in Epilepsy

Figure 14. Global Gabapentin Market: Epilepsy (2016-2021) & (M Unit)

Figure 15. Gabapentin Consumed in Neuropathic Pain

Figure 16. Global Gabapentin Market: Neuropathic Pain (2016-2021) & (M Unit)

Figure 17. Gabapentin Consumed in Restless Legs Syndrome

Figure 18. Global Gabapentin Market: Restless Legs Syndrome (2016-2021) & (M Unit)

Figure 19. Gabapentin Consumed in Others

Figure 20. Global Gabapentin Market: Others (2016-2021) & (M Unit)

Figure 21. Global Gabapentin Sales Market Share by Application (2016-2021)

Figure 22. Global Gabapentin Revenue Market Share by Application in 2020

Figure 23. Gabapentin Revenue Market by Company in 2020 ($ Million)

Figure 24. Global Gabapentin Revenue Market Share by Company in 2020

Figure 25. Global Gabapentin Sales Market Share by Regions (2016-2021)

Figure 26. Global Gabapentin Revenue Market Share by Region in 2020

Figure 27. Americas Gabapentin Sales 2016-2021 (M Unit)

Figure 28. Americas Gabapentin Revenue 2016-2021 ($ Millions)

Figure 29. APAC Gabapentin Sales 2016-2021 (M Unit)

Figure 30. APAC Gabapentin Revenue 2016-2021 ($ Millions)

Figure 31. Europe Gabapentin Sales 2016-2021 (M Unit)

Figure 32. Europe Gabapentin Revenue 2016-2021 ($ Millions)

Figure 33. Middle East & Africa Gabapentin Sales 2016-2021 (M Unit)

Figure 34. Middle East & Africa Gabapentin Revenue 2016-2021 ($ Millions)

Figure 35. Americas Gabapentin Sales Market Share by Country in 2020

Figure 36. Americas Gabapentin Revenue Market Share by Country in 2020

Figure 37. Americas Gabapentin Sales Market Share by Type in 2020

Figure 38. Americas Gabapentin Sales Market Share by Application in 2020

Figure 39. United States Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 40. Canada Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 41. Mexico Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 42. Brazil Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 43. APAC Gabapentin Sales Market Share by Region in 2020

Figure 44. APAC Gabapentin Revenue Market Share by Regions in 2020

Figure 45. APAC Gabapentin Sales Market Share by Type in 2020

Figure 46. APAC Gabapentin Sales Market Share by Application in 2020

Figure 47. China Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 48. Japan Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 49. Korea Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 50. Southeast Asia Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 51. India Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 52. Australia Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 53. Europe Gabapentin Sales Market Share by Country in 2020

Figure 54. Europe Gabapentin Revenue Market Share by Country in 2020

Figure 55. Europe Gabapentin Sales Market Share by Type in 2020

Figure 56. Europe Gabapentin Sales Market Share by Application in 2020

Figure 57. Germany Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 58. France Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 59. UK Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 60. Italy Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 61. Russia Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 62. Middle East & Africa Gabapentin Sales Market Share by Country in 2020

Figure 63. Middle East & Africa Gabapentin Revenue Market Share by Country in 2020

Figure 64. Middle East & Africa Gabapentin Sales Market Share by Type in 2020

Figure 65. Middle East & Africa Gabapentin Sales Market Share by Application in 2020

Figure 66. Egypt Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 67. South Africa Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 68. Israel Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 69. Turkey Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 70. GCC Country Gabapentin Revenue Growth 2016-2021 ($ Millions)

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

Sample Request is not available